Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-02-08
2005-02-08
Berch, Mark L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S284000, C544S238000, C544S353000, C544S405000, C546S167000, C546S270400, C548S190000, C514S255050, C514S266200, C514S340000, C514S370000
Reexamination Certificate
active
06852720
ABSTRACT:
A compound selected from those of formula (I):wherein:R1, R2, R3are as defined in the description, and optionally, its optical isomers, N-oxide, and addition salts thereof with a pharmaceutically-acceptable acid or base, and medicinal products containing the same are useful as inhibitors of phosphosdiesterase-7.
REFERENCES:
Thomas A. Godwin (Gastrointestinal Diseases, <http://edcenter.med.cornell.edu/CUMC_PathNotes/Gastrointestinal/Gastrointestinal.html>, 51 pages).*
Nakata, Clin. Exp. Immunol. 2002 128: 460 (2002).*
Gardner, Biochemical and Biophysical Research Communications 272, 186 (2000).*
J. Pharm. Sci, 1977, 66, 1-19.
Bernardelli Patrick
Ducrot Pierre
Lorthiois Edwige
Vergne Fabrice
Benson Gregg C.
Berch Mark L.
Habte Kahsay
Pfizer Inc.
Richardson Peter C.
LandOfFree
Thiazol-2-yl-imine compounds as PDE-7 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thiazol-2-yl-imine compounds as PDE-7 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiazol-2-yl-imine compounds as PDE-7 inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3445782